0
0.5
1
1.5
2+
Mortality
37%
Improvement
Relative Risk
Remdesivir for COVID-19 Salehi et al. ICU PATIENTS
Is very late treatment with remdesivir beneficial for COVID-19?
Retrospective 125 patients in Iran (April - September 2021)
Lower mortality with remdesivir (p=0.011)
c19early.org
Salehi et al., Research Square, March 2022
Favors remdesivir
Favors control